Physician profile
Matthew Partain
NPI 1174917280
$2,221.24
in general payments reported to CMS, 2019-2025
6 companies · $1,553 in 2025
The $1,553 reported for 2025 was more than what 88% of Pediatric Otolaryngology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $186 · 2023: $307 · 2024: $174 · 2025: $1,553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,168 · Food and Beverage: $866.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,168.47 |
| Food and Beverage | $866.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,410.67 | 2025 | Tula, Rf20000 |
| Inspire Medical Systems, INC. | $316.68 | 2023-2025 | Inspire |
| Cochlear Americas | $260.06 | 2022-2023 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant, Baha |
| Integra Lifesciences Corporation | $158.12 | 2024 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Depuy Synthes Sales INC. | $38.59 | 2023 | Matrixmandible, Trumatch |
| Advanced Bionics, LLC | $37.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Partain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.